Hangzhou Diagens Biotechnology's (HKG:2526) shares opened 121.2% above their initial public offering price in a stellar Hong Kong debut on Monday morning.
The Chinese biotechnology company opened at HK$219.00 per share, compared with the offer price of HK$99.00.